134 related articles for article (PubMed ID: 27357718)
21. Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values.
Cui R; Du Y; Tian N; Jiang HL; Tao YL; Dai SM
Clin Exp Rheumatol; 2023 May; 41(5):1163-1169. PubMed ID: 36226617
[TBL] [Abstract][Full Text] [Related]
22. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
[TBL] [Abstract][Full Text] [Related]
23. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
DU XN; Li Y; Zhang SL; Zhu J; Huang F
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
[TBL] [Abstract][Full Text] [Related]
24. [Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].
Bobek D; Zagar I; Kovač-Durmiš K; Perić P; Ćurković B; Babić-Naglić Ð
Reumatizam; 2012; 59(1):5-10. PubMed ID: 25486721
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Intra-articular Sacroiliac Glucocorticoid Injections in Ankylosing Spondylitis.
Nam B; Kim TH; Lee SW; Kim H; Kim YJ; Jun JB; Lee S
J Clin Rheumatol; 2022 Jan; 28(1):e26-e32. PubMed ID: 33298816
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial.
Şilte Karamanlioğlu D; Aktas I; Ozkan FU; Kaysin M; Girgin N
Rheumatol Int; 2016 May; 36(5):653-61. PubMed ID: 26923690
[TBL] [Abstract][Full Text] [Related]
27. The electronic medical record management systems may improve monitoring and control of disease activity in patients with ankylosing spondylitis.
Huang PJ; Chen YH; Huang WN; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Chen YJ; Liao YW; Liu YT; Chen HH
Sci Rep; 2023 Mar; 13(1):3957. PubMed ID: 36894589
[TBL] [Abstract][Full Text] [Related]
28. Add-On Effects of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs in Ankylosing Spondylitis: Data from a Real-World Registered Study in China.
Man S; Ji X; Wang Y; Ma Y; Hu Z; Zhu J; Zhang J; Huang F
Med Sci Monit; 2020 Jan; 26():e921055. PubMed ID: 31959738
[TBL] [Abstract][Full Text] [Related]
29. [The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis].
Liu B; Guo CY; Liu WQ; Wu N; Xing Q
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):566-9. PubMed ID: 16194404
[TBL] [Abstract][Full Text] [Related]
30. Ankylosing Spondylitis patients with Type D personality have worse clinical status.
Erkol İnal E; Demirci K; Doğru A; Şahin M
Mod Rheumatol; 2016; 26(1):138-45. PubMed ID: 26011439
[TBL] [Abstract][Full Text] [Related]
31. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
[TBL] [Abstract][Full Text] [Related]
32. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.
Gentileschi S; Vitale A; Rigante D; Lopalco G; Emmi G; Orlando I; Di Scala G; Sota J; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Iannone F; Cantarini L
Isr Med Assoc J; 2018 Jul; 20(7):438-441. PubMed ID: 30109794
[TBL] [Abstract][Full Text] [Related]
33. The relationship between CRP gene polymorphism (rs2794521, rs3091244), ASDAS-CRP and ASDAS-ESR in ankylosing spondylitis.
Kasapoğlu Aksoy M; Altan L; Görükmez O; Güner A; Ayar K
Mod Rheumatol; 2020 Jul; 30(4):715-720. PubMed ID: 31267817
[No Abstract] [Full Text] [Related]
34. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
[TBL] [Abstract][Full Text] [Related]
35. A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis.
Cinar M; Yilmaz S; Cinar FI; Koca SS; Erdem H; Pay S; Dinc A; Yazici Y; Simsek I
Rheumatol Int; 2015 Sep; 35(9):1575-80. PubMed ID: 25794571
[TBL] [Abstract][Full Text] [Related]
36. The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis.
Özdemirel AE; Güven SC; Sunar İ; Sari Sürmeli Z; Doğanci A; Tutkak H; Yalçin Sayin AP; Ataman Ş
Int J Clin Pract; 2022; 2022():7243399. PubMed ID: 35685583
[TBL] [Abstract][Full Text] [Related]
37. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.
van der Heijde D; Lie E; Kvien TK; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R;
Ann Rheum Dis; 2009 Dec; 68(12):1811-8. PubMed ID: 19060001
[TBL] [Abstract][Full Text] [Related]
38. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
Vastesaeger N; Cruyssen BV; Mulero J; Gratacós Masmitjá J; Zarco P; Almodovar R; Font P; Juanola X; Collantes-Estevez E;
Reumatol Clin; 2014; 10(4):204-9. PubMed ID: 24598027
[TBL] [Abstract][Full Text] [Related]
39. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.
Park SH; Choe JY; Kim SK; Lee H; Castrejón I; Pincus T
J Clin Rheumatol; 2015 Sep; 21(6):300-4. PubMed ID: 26308349
[TBL] [Abstract][Full Text] [Related]
40. Aerobic capacity and its correlates in patients with ankylosing spondylitis.
Hsieh LF; Wei JC; Lee HY; Chuang CC; Jiang JS; Chang KC
Int J Rheum Dis; 2016 May; 19(5):490-9. PubMed ID: 24754841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
